Bloodstream infections in patients with kidney disease: risk factors for poor outcome and mortality.

PubWeight™: 1.55‹?› | Rank: Top 4%

🔗 View Article (PMID 24001997)

Published in J Hosp Infect on August 31, 2013

Authors

L Rojas1, P Muñoz, M Kestler, D Arroyo, M Guembe, M Rodríguez-Créixems, E Verde, E Bouza

Author Affiliations

1: Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Articles by these authors

Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med (1992) 8.15

The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group. Kidney Int Suppl (1998) 3.50

A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group. N Engl J Med (1995) 3.04

Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache (1999) 2.61

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect (2014) 2.47

Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill (2008) 2.43

Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrob Agents Chemother (2001) 2.42

Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology (2004) 2.41

Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect (2011) 2.38

Accuracy of genomic selection methods in a standard data set of loblolly pine (Pinus taeda L.). Genetics (2012) 2.33

Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1995) 2.14

Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect (2009) 2.13

Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals. Antimicrob Agents Chemother (2007) 2.04

[Antimicrobial therapy in exacerbated chronic obstructive pulmonary disease]. Arch Bronconeumol (2002) 2.03

Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin. Antimicrob Agents Chemother (2002) 2.00

Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study. Medicine (Baltimore) (2001) 2.00

Visceral leishmaniasis in immunocompromised hosts. Am J Med (1987) 1.99

Evaluation of an immunological score to assess the risk of severe infection in heart recipients. Transpl Infect Dis (2014) 1.98

The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era. Clin Infect Dis (2013) 1.91

Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV). Ann Intern Med (1989) 1.82

Evolution of susceptibilities of Campylobacter spp. to quinolones and macrolides. Antimicrob Agents Chemother (1994) 1.78

Evaluation of a new system, VITEK 2, for identification and antimicrobial susceptibility testing of enterococci. J Clin Microbiol (2000) 1.78

Central nervous system infection caused by Pseudallescheria boydii: case report and review. Rev Infect Dis (1990) 1.73

Multiply antibiotic-resistant Streptococcus pneumoniae recovered from Spanish hospitals (1988-1994): novel major clones of serotypes 14, 19F and 15F. Microbiology (1996) 1.69

Risk for developing tuberculosis among anergic patients infected with HIV. Ann Intern Med (1993) 1.69

Accelerating the domestication of trees using genomic selection: accuracy of prediction models across ages and environments. New Phytol (2011) 1.65

Evaluation of the upgraded amplified Mycobacterium tuberculosis direct test (gen-probe) for direct detection of Mycobacterium tuberculosis in respiratory and non-respiratory specimens. Diagn Microbiol Infect Dis (2001) 1.60

Evaluation of the MB/BacT mycobacterium detection system for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol (2000) 1.59

Failure of ciprofloxacin therapy for invasive nontyphoidal salmonellosis. Clin Infect Dis (1998) 1.59

Klebsiella bacteremia: an analysis of 100 episodes. Rev Infect Dis (1985) 1.56

Thalidomide in patients with acquired immunodeficiency syndrome. Arch Intern Med (1992) 1.56

Yersinia enterocolitica Septicemia. Am J Clin Pathol (1980) 1.54

"Second-look" cytotoxicity: an evaluation of culture plus cytotoxin assay of Clostridium difficile isolates in the laboratory diagnosis of CDAD. J Hosp Infect (2001) 1.49

Comparison of three commercial methods for rapid detection of Clostridium difficile toxins A and B from fecal specimens. J Clin Microbiol (2008) 1.49

Trisomy 8: an additional case with unique manifestations [correction]. Am J Med Genet (1992) 1.47

[Calciphylaxis: fatal complication of cardiometabolic syndrome in patients with end stage kidney disease]. Nefrologia (2008) 1.47

A European perspective on nosocomial urinary tract infections I. Report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI-003 study). European Study Group on Nosocomial Infections. Clin Microbiol Infect (2001) 1.45

Candida infective endocarditis. Eur J Clin Microbiol Infect Dis (2008) 1.41

A European perspective on nosocomial urinary tract infections II. Report on incidence, clinical characteristics and outcome (ESGNI-004 study). European Study Group on Nosocomial Infection. Clin Microbiol Infect (2001) 1.40

Fetal IgG specificities against Trypanosoma cruzi antigens in infected newborns. Proc Natl Acad Sci U S A (1990) 1.39

In vitro activity of linezolid against multiply resistant Gram-positive clinical isolates. J Antimicrob Chemother (2001) 1.38

Metronidazole resistance in Clostridium difficile is heterogeneous. J Clin Microbiol (2008) 1.38

Role of universal 16S rRNA gene PCR and sequencing in diagnosis of prosthetic joint infection. J Clin Microbiol (2011) 1.37

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. Clin Microbiol Infect (2014) 1.36

A conservative procedure for the diagnosis of catheter-related infections. Arch Intern Med (1990) 1.36

Susceptibility of Streptococcus pneumoniae to penicillin: a prospective microbiological and clinical study. Clin Infect Dis (1992) 1.34

[Use of antibiotics in exacerbated chronic obstructive pulmonary disease]. Aten Primaria (2001) 1.31

Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain. Antimicrob Agents Chemother (2007) 1.28

Infective endocarditis--a prospective study at the end of the twentieth century: new predisposing conditions, new etiologic agents, and still a high mortality. Medicine (Baltimore) (2001) 1.28

Developmental regulation of GLUT-1 (erythroid/Hep G2) and GLUT-4 (muscle/fat) glucose transporter expression in rat heart, skeletal muscle, and brown adipose tissue. Endocrinology (1992) 1.28

Ocular tuberculosis. A prospective study in a general hospital. Medicine (Baltimore) (1997) 1.28

Monitoring mortality as an indicator of influenza in Catalonia, Spain. J Epidemiol Community Health (1996) 1.27

Infections in hairy-cell leukemia. Blood (1978) 1.26

Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy. Clin Infect Dis (2000) 1.23

Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain. Clin Microbiol Infect (2013) 1.23

Prolonged viral shedding in pandemic influenza A(H1N1): clinical significance and viral load analysis in hospitalized patients. Clin Microbiol Infect (2010) 1.23

Group-C beta-hemolytic streptococcal bacteremia. Diagn Microbiol Infect Dis (1992) 1.22

Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998-1999. Antimicrob Agents Chemother (2001) 1.22

Group G streptococcal endocarditis. Am J Clin Pathol (1978) 1.22

Infectious osteitis pubis. Urology (1978) 1.22

Brucellar meningitis. Rev Infect Dis (1988) 1.22

Leuconostoc species as a cause of bacteremia: two case reports and a literature review. Eur J Clin Microbiol Infect Dis (1991) 1.17

Rapid detection of toxigenic Clostridium difficile from stool samples by a nested PCR of toxin B gene. J Hosp Infect (1999) 1.17

Nasal carriage of S. aureus increases the risk of surgical site infection after major heart surgery. J Hosp Infect (2007) 1.17

Group A streptococcal bacteremia. A 10-year prospective study. Medicine (Baltimore) (1997) 1.16

In vitro activity of the new glycopeptide LY333328 against multiply resistant gram-positive clinical isolates. Antimicrob Agents Chemother (1998) 1.15

Rhodococcus equi infection in transplant recipients: case report and review of the literature. Transplantation (1998) 1.14

Factors predicting mortality in elderly patients on dialysis. Nephron Clin Pract (2010) 1.12

Lemierre's disease: postanginal bacteremia and pulmonary involvement caused by Fusobacterium necrophorum. Rev Infect Dis (1989) 1.12

Workload due to Aspergillus fumigatus and significance of the organism in the microbiology laboratory of a general hospital. J Clin Microbiol (2005) 1.11

Group B Streptococcus: a cause of urinary tract infection in nonpregnant adults. Clin Infect Dis (1992) 1.11

Molecular analysis of relapse vs re-infection in HIV-positive patients suffering from recurrent Clostridium difficile associated diarrhoea. J Hosp Infect (2001) 1.11

Catheter-related infections: diagnosis and intravascular treatment. Clin Microbiol Infect (2002) 1.11

Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study. Clin Microbiol Infect (2004) 1.09

Antifungal susceptibility of 596 Aspergillus fumigatus strains isolated from outdoor air, hospital air, and clinical samples: analysis by site of isolation. Antimicrob Agents Chemother (2005) 1.09

Streptococcus pneumoniae in community-acquired respiratory tract infections in Spain: the impact of serotype and geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibiotics. The Spanish Surveillance Group for Respiratory Pathogens. J Antimicrob Chemother (2000) 1.09

Pneumonia treated in the internal medicine department: focus on healthcare-associated pneumonia. Clin Microbiol Infect (2012) 1.09

Coccidioidal meningitis. An analysis of thirty-one cases and review of the literature. Medicine (Baltimore) (1981) 1.07

Effect of diabetes and fasting on GLUT-4 (muscle/fat) glucose-transporter expression in insulin-sensitive tissues. Heterogeneous response in heart, red and white muscle. Biochem J (1992) 1.06

In vitro activities of six fluoroquinolones against 250 clinical isolates of Mycobacterium tuberculosis susceptible or resistant to first-line antituberculosis drugs. Antimicrob Agents Chemother (2000) 1.06

Postsurgical mediastinitis: a case-control study. Clin Infect Dis (1997) 1.06

Restoration of humoral immunity after intravenous immunoglobulin replacement therapy in heart recipients with post-transplant antibody deficiency and severe infections. Clin Transplant (2012) 1.06

Insulin-induced recruitment of glucose transporter 4 (GLUT4) and GLUT1 in isolated rat cardiac myocytes. Evidence of the existence of different intracellular GLUT4 vesicle populations. J Biol Chem (1997) 1.06

Extra-intestinal infections caused by Clostridium difficile. Clin Microbiol Infect (2001) 1.06

Clinical manifestations, treatment and control of infections caused by Clostridium difficile. Clin Microbiol Infect (2005) 1.05

Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Spain: a multicentre prevalence study (2002). Clin Microbiol Infect (2007) 1.05